文章基本信息

标题：Trifolium pratense L.: uma alternativa para o tratamento de sintomas vasoativos em mulheres pré e pós-menopausa
本地全文：下载
作者：Anna Cyntia Brandão Nascimento Maniçoba ; Valéria Maria Sousa Leitão ; Maria Beatriz Coutinho Moraes 等
期刊名称：Research, Society and Development
电子版ISSN：2525-3409
出版年度：2022
卷号：11
期号：12
页码：1-13
DOI：10.33448/rsd-v11i12.34695
语种：English
出版社：Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
摘要：Menopausal women experience estrogen deficiency during this period, which causes vasomotor symptoms such as mood swings, hot flushes, palpitations, headache, irritation, and depression. There are several pharmacological treatments as well as the use of dietary supplements to control these clinical manifestations, however therapies from medicinal plants have been highlighted, among them Trifolium pratense L. Popularly known as Red clover, it has a record in the Therapeutic Memento and in the Anvisa's Herbal Medicines Form, being considered a therapeutic adjunct in the treatment of climacteric. An integrative and narrative review using the Cochrane Central Register of Controlled Trials (CENTRAL), Cumulative Index for Nursing and Allied Health Literature (CINAHL; www.ebscohost.com/cinahl/), Embase, PubMed, LILACS, MEDLINE, PsycINFO and Web of Science as keywords adopted: “Trifolium pratense”, “clinical trial” and “hot flashes”. As a complement to the review, protocols for studies and ongoing trials were searched on CriticalTrials.gov. What resulted after analysis of the articles, 7 records. It is noted that the plant species studied exhibits a wealth of isoflavones in its composition, these metabolites are considered selective modulators of estrogen receptors, and can act as agonist and antagonist of estrogen receptors. Significant results were observed with Trifolium pratense in relieving hot flashes in women, however further trials are needed to safely define this clinical practice.
关键词：Red clover;Clinical trial;Hot flashes.